Clinical Trial Update: General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating AJG555 for chronic constipation in pediatric patients has completed. The study is sponsored by EA Pharma Co., Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• AJG555

Snippet

Sponsor: EA Pharma Co., Ltd. | Conditions: Chronic Constipation | Phase 3 | Status: COMPLETED